

| 货号 | JN929010 |
|---|---|
| 品牌 | abinScience |
| 描述 |
InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202) [Iv0202] (JN929010) is a alpaca monoclonal antibody detecting Protein glycosylation K in ELISA, Neutralization.
|
| 种属反应性 | Campylobacter jejuni |
| 应用 | ELISA, Neutralization |
| 宿主 | Alpaca |
| 同种型 | VHH-8His-Cys-tag |
| 克隆号 | Iv0202 |
| 克隆类型 | Monoclonal |
| 靶标 | Protein glycosylation K, 7.5.2.5, pglK, wlaB, Cj1130c |
| 内毒素水平 | <0.01 EU/ug |
| 纯度 | >95% as determined by SDS-PAGE. |
| 相关产品 | pH 7.4 Dilution Buffer |
| 纯化方式 | Purified by Nickel column. |
| Accession号 | Q0P9C4 |
| 状态 | Liquid |
| 保存溶液 | 0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 背景 | Protein glycosylation K (wlaB/pglK) is a ~64 kDa protein. Mediates the ATP-dependent translocation of the undecaprenylpyrophosphate-linked heptasaccharide intermediate across the cell membrane; this is an essential step during the N-linked protein glycosylation pathway. Transport across the membrane is effected via ATP-driven conformation changes. Most likely, only the polar and charged part of the glycolipid enter the substrate-binding cavity, and the lipid tail remains exposed to the membrane lipids during the transmembrane flipping process. |
| Note | For research use only. Not suitable for clinical or therapeutic use. |

SDS-PAGE for InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202).



24小时产品查询

扫一扫关注我们

专属渠道经理